Spruce Biosciences, Inc. (SPRB) Operating cash flow 2019–2025
Spruce Biosciences, Inc. (SPRB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.3MFY2025 · since FY2019: -$12.6M → -$33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.3M | +40.4% |
| FY2024 | -$56.0M | -68.2% |
| FY2023 | -$33.3M | +20.2% |
| FY2022 | -$41.7M | -16.2% |
| FY2021 | -$35.9M | -30.4% |
| FY2020 | -$27.5M | -118.1% |
| FY2019 | -$12.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating marginSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →